mint - Science
Elon Musk's next target: Restoring eye sight, expects human trials in 6 months
Elon Musk's Neuralink is expecting to get USFDA approval for conducting human trials under its human eye sight restoration project. The company will begin human clinical trials in six months
from mint - Science https://ift.tt/D3KCMim
from mint - Science https://ift.tt/D3KCMim
Post a Comment
0 Comments